Chronic inflammation is one of the largest unsolved healthcare issues of our society. Lifestyle adjustments such as optimized diets or increased physical activity are effective to fight chronic inflammations. However, every individual requires a different set of personalized adjustments. Unfortunately, there is currently no way to tailor the optimal anti-inflammatory measures to the personal needs of chronically inflamed individuals.
Hemetron develops a uniquely accurate and quantitative blood test for inflammation self-monitoring. Our solution empowers users to determine how to effectively decrease their inflammation.
During our GRS InnoBooster project, we convert our hand-held prototype into a mass producible beta product. This product will then be validated to ensure optimal performance. These steps allow us to move forward with user-testing to optimize the device for the needs of the customers and accelerate our market entry.
Persons involved in the project
Last update to this project presentation 18.07.2022